Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

60 Degrees Pharmaceuticals (SXTP) Net Income towards Common Stockholders (2022 - 2025)

60 Degrees Pharmaceuticals (SXTP) has disclosed Net Income towards Common Stockholders for 4 consecutive years, with -$2.3 million as the latest value for Q3 2025.

  • On a quarterly basis, Net Income towards Common Stockholders fell 1.97% to -$2.3 million in Q3 2025 year-over-year; TTM through Sep 2025 was -$8.2 million, a 1.11% increase, with the full-year FY2024 number at -$8.4 million, down 114.81% from a year prior.
  • Net Income towards Common Stockholders was -$2.3 million for Q3 2025 at 60 Degrees Pharmaceuticals, down from -$1.7 million in the prior quarter.
  • In the past five years, Net Income towards Common Stockholders ranged from a high of $4.1 million in Q3 2023 to a low of -$4.3 million in Q2 2024.
  • A 4-year average of -$1.6 million and a median of -$2.1 million in 2022 define the central range for Net Income towards Common Stockholders.
  • Peak YoY movement for Net Income towards Common Stockholders: skyrocketed 1771.2% in 2023, then plummeted 749.38% in 2025.
  • 60 Degrees Pharmaceuticals' Net Income towards Common Stockholders stood at -$1.7 million in 2022, then dropped by 25.37% to -$2.1 million in 2023, then dropped by 4.93% to -$2.2 million in 2024, then decreased by 6.29% to -$2.3 million in 2025.
  • Per Business Quant, the three most recent readings for SXTP's Net Income towards Common Stockholders are -$2.3 million (Q3 2025), -$1.7 million (Q2 2025), and -$2.0 million (Q1 2025).